Feilan Chen

599 total citations
25 papers, 410 citations indexed

About

Feilan Chen is a scholar working on Molecular Biology, Ophthalmology and Epidemiology. According to data from OpenAlex, Feilan Chen has authored 25 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Ophthalmology and 5 papers in Epidemiology. Recurrent topics in Feilan Chen's work include Ocular Diseases and Behçet’s Syndrome (9 papers), Systemic Lupus Erythematosus Research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Feilan Chen is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (9 papers), Systemic Lupus Erythematosus Research (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). Feilan Chen collaborates with scholars based in China, United States and Netherlands. Feilan Chen's co-authors include Zhaohua Tang, Zili Liu, Jie Gao, Yan Chen, Yongguo Li, Shengping Hou, Peizeng Yang, Zhengxuan Jiang, Qinmeng Shu and Fuzhen Li and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Feilan Chen

23 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feilan Chen China 10 211 114 75 58 53 25 410
Leizhou Xia China 11 231 1.1× 63 0.6× 50 0.7× 117 2.0× 50 0.9× 21 430
Hendrika A. B. Peters Netherlands 13 246 1.2× 119 1.0× 25 0.3× 67 1.2× 151 2.8× 27 502
Órla T. Cox Ireland 12 215 1.0× 59 0.5× 36 0.5× 52 0.9× 59 1.1× 14 391
Lili Xie China 12 233 1.1× 131 1.1× 39 0.5× 35 0.6× 23 0.4× 32 405
Yaqi Cheng China 9 230 1.1× 131 1.1× 76 1.0× 50 0.9× 58 1.1× 28 358
Adil Rasheed Canada 9 232 1.1× 105 0.9× 19 0.3× 59 1.0× 159 3.0× 21 489
Sameeksha Chopra Canada 7 168 0.8× 124 1.1× 10 0.1× 87 1.5× 57 1.1× 11 438
Isabelle Aubry Canada 13 233 1.1× 43 0.4× 43 0.6× 62 1.1× 91 1.7× 26 468

Countries citing papers authored by Feilan Chen

Since Specialization
Citations

This map shows the geographic impact of Feilan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feilan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feilan Chen more than expected).

Fields of papers citing papers by Feilan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feilan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feilan Chen. The network helps show where Feilan Chen may publish in the future.

Co-authorship network of co-authors of Feilan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Feilan Chen. A scholar is included among the top collaborators of Feilan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feilan Chen. Feilan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Xinyi, et al.. (2025). Plasma Metabolic Profiles of Chronic and Recurrent Uveitis Treated by Artesunate in Lewis Rats. Biomedicines. 13(4). 821–821.
2.
Lv, Longbao, Hui Huang, Jie Gao, et al.. (2022). A Novel Tree Shrew Model of Chronic Experimental Autoimmune Uveitis and Its Disruptive Application. Frontiers in Immunology. 13. 889596–889596. 4 indexed citations
3.
Tang, Zhaohua, Zhengbu Liao, Feilan Chen, et al.. (2022). Tanshinone IIA reduces AQP4 expression and astrocyte swelling after OGD/R by inhibiting the HMGB1/RAGE/NF-κB/IL-6 pro-inflammatory axis. Scientific Reports. 12(1). 14110–14110. 19 indexed citations
4.
Wu, Jun, Jingrui Wang, Niloofar Piri, et al.. (2021). Short chain fatty acids inhibit endotoxin-induced uveitis and inflammatory responses of retinal astrocytes. Experimental Eye Research. 206. 108520–108520. 37 indexed citations
5.
Gao, Jie, et al.. (2020). Parental Uveitis Influences Offspring With an Increased Susceptibility to the Experimental Autoimmune Uveitis. Frontiers in Immunology. 11. 1053–1053. 1 indexed citations
6.
Tang, Zhaohua, Yongguo Li, Zili Liu, et al.. (2020). Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas. Cancer Cell International. 20(1). 1–1. 169 indexed citations
7.
Lan, Xiqian, Vinod Kumar, Rukhsana Aslam, et al.. (2020). EDA2R mediates podocyte injury in high glucose milieu. Biochimie. 174. 74–83. 20 indexed citations
8.
Tang, Zhaohua, Gang Yang, Xiaoshu Wang, et al.. (2020). AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation. Journal of Neuro-Oncology. 149(2). 231–242. 16 indexed citations
9.
Tang, Zhaohua, Wentao Wang, Zili Liu, et al.. (2020). [Blocking ERK signaling pathway lowers MMP-9 expression to alleviate brain edema after traumatic brain injury in rats].. 40(7). 1018–1022. 3 indexed citations
10.
Tang, Zhaohua, Wentao Wang, Zili Liu, et al.. (2020). [Blocking ERK signaling pathway lowers MMP-9 expression to alleviate brain edema after traumatic brain injury in rats].. PubMed. 40(7). 1018–1022. 3 indexed citations
11.
Xu, Lei, et al.. (2019). PRKCQ rs4750316 is associated with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.. PubMed. 25. 834–842. 3 indexed citations
12.
Liu, Zili, Zhaohua Tang, Feilan Chen, et al.. (2018). [Erythropoietin accelerates the proliferation of glioma cells via activating Akt pathway].. PubMed. 38(4). 395–401. 2 indexed citations
13.
Chen, Feilan, et al.. (2016). Occupational Toxicological Characteristics of LLM-105 Explosives. 1(3). 88. 1 indexed citations
14.
Chen, Feilan, Lei Xu, Tingting Zhao, et al.. (2016). Genetic Variation in the REL Gene Increases Risk of Behcet’s Disease in a Chinese Han Population but That of PRKCQ Does Not. PLoS ONE. 11(1). e0147350–e0147350. 10 indexed citations
15.
Chen, Feilan, et al.. (2016). Clinical and Pathologic Features of a Suspected Selenium Deficiency in Captive Plains Zebras. Biological Trace Element Research. 176(1). 114–119. 7 indexed citations
16.
Hou, Shengping, Qinmeng Shu, Zhengxuan Jiang, et al.. (2012). Replication study confirms the association between UBAC2 and Behçet's disease in two independent Chinese sets of patients and controls. Arthritis Research & Therapy. 14(2). R70–R70. 34 indexed citations
17.
Chen, Feilan, Shengping Hou, Yuling Chen, et al.. (2011). CD40 gene polymorphisms confer risk of Behcet's disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Lara D. Veeken. 51(1). 47–51. 30 indexed citations
18.
Chen, Feilan, Xiaohong Yao, Rong Zhang, et al.. (2010). Human malignant glioma cells expressing functional formylpeptide receptor recruit endothelial progenitor cells for neovascularization. International Immunopharmacology. 10(12). 1602–1607. 8 indexed citations
19.
Chen, Feilan, et al.. (2008). Incorporation of endothelial progenitor cells into the neovasculature of malignant glioma xenograft. Journal of Neuro-Oncology. 93(2). 165–174. 23 indexed citations
20.
Zhang, Huarong, et al.. (2008). [Effect of nordy on the function of endothelial progenitor cells from human umbilical cord blood induced by vascular endothelial growth factor].. PubMed. 43(2). 133–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026